Vision
With appropriate planning at the global, regional, and national levels, governments of malaria-endemic countries will have the information they need to make timely and evidence-based decisions on the use of a malaria vaccine.
Origin
Development of the Malaria Vaccine Decision-Making Framework has involved work to identify the information that African ministries of health would need to decide on malaria vaccine use.The work was launched at a 2006 workshop in Benin that was hosted by the country’s Minister of Health and organized by the PATH Malaria Vaccine Initiative (MVI) and the World Health Organization (WHO).
With African experts on malaria, immunization, and health systems, and other partners attending, work began on a generic planning tool. A series of national consultations followed. MVI and WHO met with stakeholders from Gabon, Ghana, Kenya, Mali, Mozambique, and Tanzania to adapt the tool to reflect the distinct circumstances of their respective health systems. The meetings brought together representatives from ministries of health, planning, and finance; WHO and the United Nations Children’s Fund; bilateral development partners; malaria scientists; and nongovernmental organizations.
The six consultations produced country-specific decision-making tools. The six tools were later synthesized into a draft regional framework that was reviewed by other countries. The framework was validated in 2008 at sub-regional meetings in East and Southern Africa, West Africa, and Central Africa as a tool for countries. These meetings, which included malaria, immunization, and other technical experts from 30 countries, were supported by WHO and the Roll Back Malaria Partnership Secretariat.
Additional resources
EVIPNet: Evidence-Informed Policy Network, World Health Organization
SIVAC: Supporting National Independent Immunization and Vaccine Advisory Committees